Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P Balachandran, Marta Luksza, Julia N Zhao, Vladimir Makarov, John Alec Moral, Romain Remark, Brian Herbst, Gokce Askan, Umesh Bhanot, Yasin Senbabaoglu, Daniel K Wells, Charles Ian Ormsby Cary, Olivera Grbovic-Huezo, Marc Attiyeh, Benjamin Medina, Jennifer Zhang, Jennifer Loo, Joseph Saglimbeni, Mohsen Abu-Akeel, Roberta Zappasodi Show all
Nature | NATURE PUBLISHING GROUP | Published : 2017
Awarded by National Institutes of Health (NIH) (Pancreatic Cancer Action Network-AACR Research Acceleration Network Grant)
Awarded by National Institutes of Health (NIH)
Awarded by National Cancer Institute
Awarded by National Cancer Institute Cancer Center Support Grant
We thank A. Rudensky, A. Snyder-Charan, C. Callan, Y. Elhanati, Z. Sethna, J. Leung, J. Ruan, C. Crabtree, P. Garcia, M. Singh, A. McNeil, D. Haviland, J. Melchor and J. Tsoi for discussions, technical and editorial assistance. This work was supported by National Institutes of Health (NIH) R01DK097087-01 Pancreatic Cancer Action Network-AACR Research Acceleration Network Grant (S. D. L.), P30 CA008748-50S4 administrative supplement (S. D. L., V. P. B.), Suzanne Cohn Simon Pancreatic Cancer Research Fund (S. D. L.), National Cancer Institute K12CA184746-01A1 (V. P. B.), Damon Runyon Clinical Investigator Award (V. P. B.), Stand Up to Cancer, Lustgarden Foundation, and the National Science Foundation (J. D. W., B. D. G.), the V Foundation (V. P. B., J. A. M., J. D. W., B. D. G.), the Phil A. Sharp Innovation Award (B. D. G., J. D. W.), Swim Across America, and the Ludwig Institute for Cancer Research (J. D. W., T. M.), and the Parker Institute for Cancer Immunotherapy (D. K. W., C. I. O. C., J. D. W., T. M.). Services by the Integrated Genomics Core were funded by the National Cancer Institute Cancer Center Support Grant (P30 CA08748), Cycle for Survival, and the Marie-Josee and Henry R. Kravis Center for Molecular Oncology.